Kenya signs renewed five-year health alliance with UK
By Emmanuel Rono, July 28, 2026Kenya has signed a renewed five-year Kenya–UK Health Alliance Memorandum of Understanding (MoU), marking a step in strengthening cooperation on healthcare workforce development, research, innovation, and pharmaceutical manufacturing.
The agreement was signed on Tuesday , July 28, 2026, at King’s College London in the presence of Principal Secretary for Medical Services Dr. Ouma Oluga, Education Cabinet Secretary Julius Migos Ogamba and Kenya’s High Commissioner to the United Kingdom, Ambassador Maurice Makoloo.
The renewed pact will deepen collaboration between Kenyan and British health institutions, universities, researchers, and training centers with the aim of improving access to quality healthcare in both countries.
Speaking through his X account after the signing, Ogamba said the partnership reflects Kenya’s commitment to building a stronger and more self-reliant health system.
“Education and training are at the heart of strengthening health systems through the development of a skilled health workforce, the advancement of research and innovation, and the establishment of a strong foundation for domestic pharmaceutical manufacturing,” he said.
Importance of the signed agreement to Kenya
The Cabinet Secretary said the agreement will support investments in training healthcare professionals, expanding research collaborations, and promoting innovation in the health sector.
“The renewed five-year Memorandum of Understanding will strengthen collaboration between Kenyan and UK institutions and researchers with the aim of enhancing access to quality healthcare,” Ogamba said.
He added that the partnership will also support strategic initiatives that contribute to better health outcomes, including knowledge exchange, joint research projects, and institutional partnerships.
The signing comes as Kenya continues to pursue reforms aimed at improving healthcare delivery, increasing the number of skilled health workers, and expanding local pharmaceutical production.
“The partnership will advance investments in health workforce development, promote research and innovation, and support other strategic initiatives that contribute to improved health outcomes in both countries,” Ogamba said.